Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1994 Aug;102(8):648–654. doi: 10.1289/ehp.94102648

Frog skin opioid peptides: a case for environmental mimicry.

L H Lazarus 1, S D Bryant 1, M Attila 1, S Salvadori 1
PMCID: PMC1567309  PMID: 7895704

Abstract

Naturally occurring environmental substances often mimic endogenous substances found in mammals and are capable of interacting with specific proteins, such as receptors, with a high degree of fidelity and selectivity. Narcotic alkaloids and amphibian skin secretions, introduced into human society through close association with plants and animals through folk medicine and religious divination practices, were incorporated into the armamentarium of the early pharmacopoeia. These skin secretions contain a myriad of potent bioactive substances, including alkaloids, biogenic amines, peptides, enzymes, mucus, and toxins (noxious compounds notwithstanding); each class exhibits a broad range of characteristic properties. One specific group of peptides, the opioids, containing the dermorphins (dermal morphinelike substances) and the deltorphins (delta-selective opioids), display remarkable analgesic properties and include an amino acid with the rare (in a mammalian context) D-enantiomer in lieu of the normal L-isomer. Synthesis of numerous stereospecific analogues and conformational analyses of these peptides provided essential insights into the tertiary composition and microenvironment of the receptor "pocket" and the optimal interactions between receptor and ligand that trigger a biological response; new advances in the synthesis and receptor-binding properties of the deltorphins are discussed in detail. These receptor-specific opioid peptides act as more than mimics of endogenous opioids: their high selectivity for either the mu or delta receptor makes them formidable environmentally derived agents in the search for new antagonists for treating opiate addiction and in the treatment of a wide variety of human disorders.

Full text

PDF
648

Images in this article

648p648-a
on p.648
651Figure 2.
on p.651
652Figure 3.
on p.652

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amodeo P., Motta A., Tancredi T., Salvadori S., Tomatis R., Picone D., Saviano G., Temussi P. A. Solution structure of deltorphin I at 265 K: a quantitative NMR study. Pept Res. 1992 Jan-Feb;5(1):48–55. [PubMed] [Google Scholar]
  2. Attila M., Salvadori S., Balboni G., Bryant S. D., Lazarus L. H. Synthesis and receptor binding analysis of dermorphin hepta-, hexa- and pentapeptide analogues. Evidence for one- and two-side binding models for the mu-opioid receptor. Int J Pept Protein Res. 1993 Dec;42(6):550–559. doi: 10.1111/j.1399-3011.1993.tb00363.x. [DOI] [PubMed] [Google Scholar]
  3. Barra D., Mignogna G., Simmaco M., Pucci P., Severini C., Falconieri-Erspamer G., Negri L., Erspamer V. [D-Leu2]deltorphin, a 17 amino acid opioid peptide from the skin of the Brazilian hylid frog, Phyllomedusa burmeisteri. Peptides. 1994;15(2):199–202. doi: 10.1016/0196-9781(94)90002-7. [DOI] [PubMed] [Google Scholar]
  4. Blalock J. E., Smith E. M., Meyer W. J., 3rd The pituitary-adrenocortical axis and the immune system. Clin Endocrinol Metab. 1985 Nov;14(4):1021–1038. doi: 10.1016/s0300-595x(85)80087-6. [DOI] [PubMed] [Google Scholar]
  5. Blaustein A. R., Hoffman P. D., Hokit D. G., Kiesecker J. M., Walls S. C., Hays J. B. UV repair and resistance to solar UV-B in amphibian eggs: a link to population declines? Proc Natl Acad Sci U S A. 1994 Mar 1;91(5):1791–1795. doi: 10.1073/pnas.91.5.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Charpentier S., Sagan S., Naim M., Delfour A., Nicolas P. Mechanism of delta-opioid receptor selection by the address domain of dermenkephalin. Eur J Pharmacol. 1994 Jan 15;266(2):175–180. doi: 10.1016/0922-4106(94)90107-4. [DOI] [PubMed] [Google Scholar]
  7. Chen Y., Mestek A., Liu J., Hurley J. A., Yu L. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol. 1993 Jul;44(1):8–12. [PubMed] [Google Scholar]
  8. Chen Y., Mestek A., Liu J., Yu L. Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors. Biochem J. 1993 Nov 1;295(Pt 3):625–628. doi: 10.1042/bj2950625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chiesa R., Silva W. I., Renaud F. L. Pharmacological characterization of an opioid receptor in the ciliate Tetrahymena. J Eukaryot Microbiol. 1993 Nov-Dec;40(6):800–804. doi: 10.1111/j.1550-7408.1993.tb04478.x. [DOI] [PubMed] [Google Scholar]
  10. Collin E., Cesselin F. Neurobiological mechanisms of opioid tolerance and dependence. Clin Neuropharmacol. 1991 Dec;14(6):465–488. doi: 10.1097/00002826-199112000-00001. [DOI] [PubMed] [Google Scholar]
  11. Comb M., Seeburg P. H., Adelman J., Eiden L., Herbert E. Primary structure of the human Met- and Leu-enkephalin precursor and its mRNA. Nature. 1982 Feb 25;295(5851):663–666. doi: 10.1038/295663a0. [DOI] [PubMed] [Google Scholar]
  12. Daly J. W., Myers C. W., Whittaker N. Further classification of skin alkaloids from neotropical poison frogs (Dendrobatidae), with a general survey of toxic/noxious substances in the amphibia. Toxicon. 1987;25(10):1023–1095. doi: 10.1016/0041-0101(87)90265-0. [DOI] [PubMed] [Google Scholar]
  13. Dumbacher J. P., Beehler B. M., Spande T. F., Garraffo H. M., Daly J. W. Homobatrachotoxin in the genus Pitohui: chemical defense in birds? Science. 1992 Oct 30;258(5083):799–801. doi: 10.1126/science.1439786. [DOI] [PubMed] [Google Scholar]
  14. Edley S. M., Hall L., Herkenham M., Pert C. B. Evolution of striatal opiate receptors. Brain Res. 1982 Oct 7;249(1):184–188. doi: 10.1016/0006-8993(82)90186-x. [DOI] [PubMed] [Google Scholar]
  15. Erspamer V. Half a century of comparative research on biogenic amines and active peptides in amphibian skin and molluscan tissues. Comp Biochem Physiol C. 1984;79(1):1–7. doi: 10.1016/0742-8413(84)90153-1. [DOI] [PubMed] [Google Scholar]
  16. Erspamer V., Melchiorri P., Broccardo M., Erspamer G. F., Falaschi P., Improota G., Negri L., Renda T. The brain-gut-skin triangle: new peptides. Peptides. 1981;2 (Suppl 2):7–16. doi: 10.1016/0196-9781(81)90003-6. [DOI] [PubMed] [Google Scholar]
  17. Erspamer V., Melchiorri P., Falconieri-Erspamer G., Negri L., Corsi R., Severini C., Barra D., Simmaco M., Kreil G. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites. Proc Natl Acad Sci U S A. 1989 Jul;86(13):5188–5192. doi: 10.1073/pnas.86.13.5188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Erspamer V. The opioid peptides of the amphibian skin. Int J Dev Neurosci. 1992;10(1):3–30. doi: 10.1016/0736-5748(92)90003-i. [DOI] [PubMed] [Google Scholar]
  19. Evans C. J., Keith D. E., Jr, Morrison H., Magendzo K., Edwards R. H. Cloning of a delta opioid receptor by functional expression. Science. 1992 Dec 18;258(5090):1952–1955. doi: 10.1126/science.1335167. [DOI] [PubMed] [Google Scholar]
  20. Feinberg A. P., Creese I., Snyder S. H. The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonists. Proc Natl Acad Sci U S A. 1976 Nov;73(11):4215–4219. doi: 10.1073/pnas.73.11.4215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H. Primary structures and expression from cDNAs of rat opioid receptor delta- and mu-subtypes. FEBS Lett. 1993 Aug 2;327(3):311–314. doi: 10.1016/0014-5793(93)81011-n. [DOI] [PubMed] [Google Scholar]
  22. Gorin F. A., Marshall G. R. Proposal for the biologically active conformation of opiates and enkephalin. Proc Natl Acad Sci U S A. 1977 Nov;74(11):5179–5183. doi: 10.1073/pnas.74.11.5179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hinrichsen R. D., Schultz J. E. Paramecium: a model system for the study of excitable cells. Trends Neurosci. 1988 Jan;11(1):27–32. doi: 10.1016/0166-2236(88)90046-x. [DOI] [PubMed] [Google Scholar]
  24. Horn A. S., Rodgers J. R. Structural and conformational relationships between the enkephalins and the opiates. Nature. 1976 Apr 29;260(5554):795–797. doi: 10.1038/260795a0. [DOI] [PubMed] [Google Scholar]
  25. Hruby V. J., Gehrig C. A. Recent developments in the design of receptor specific opioid peptides. Med Res Rev. 1989 Jul-Sep;9(3):343–401. doi: 10.1002/med.2610090306. [DOI] [PubMed] [Google Scholar]
  26. Hughes J., Smith T. W., Kosterlitz H. W., Fothergill L. A., Morgan B. A., Morris H. R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 1975 Dec 18;258(5536):577–580. doi: 10.1038/258577a0. [DOI] [PubMed] [Google Scholar]
  27. Kakidani H., Furutani Y., Takahashi H., Noda M., Morimoto Y., Hirose T., Asai M., Inayama S., Nakanishi S., Numa S. Cloning and sequence analysis of cDNA for porcine beta-neo-endorphin/dynorphin precursor. Nature. 1982 Jul 15;298(5871):245–249. doi: 10.1038/298245a0. [DOI] [PubMed] [Google Scholar]
  28. Kieffer B. L., Befort K., Gaveriaux-Ruff C., Hirth C. G. The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12048–12052. doi: 10.1073/pnas.89.24.12048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kreil G. Peptides containing a D-amino acid from frogs and molluscs. J Biol Chem. 1994 Apr 15;269(15):10967–10970. [PubMed] [Google Scholar]
  30. Köhler H., Kaveri S., Kieber-Emmons T., Morrow W. J., Müller S., Raychaudhuri S. Idiotypic networks and nature of molecular mimicry: an overview. Methods Enzymol. 1989;178:3–35. doi: 10.1016/0076-6879(89)78003-4. [DOI] [PubMed] [Google Scholar]
  31. Lazarus L. H., Attila M. The toad, ugly and venomous, wears yet a precious jewel in his skin. Prog Neurobiol. 1993 Oct;41(4):473–507. doi: 10.1016/0301-0082(93)90027-p. [DOI] [PubMed] [Google Scholar]
  32. Lazarus L. H., Ling N., Guillemin R. beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins. Proc Natl Acad Sci U S A. 1976 Jun;73(6):2156–2159. doi: 10.1073/pnas.73.6.2156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lazarus L. H., Salvadori S., Attila M., Grieco P., Bundy D. M., Wilson W. E., Tomatis R. Interaction of deltorphin with opioid receptors: molecular determinants for affinity and selectivity. Peptides. 1993 Jan-Feb;14(1):21–28. doi: 10.1016/0196-9781(93)90006-3. [DOI] [PubMed] [Google Scholar]
  34. Lazarus L. H., Salvadori S., Balboni G., Tomatis R., Wilson W. E. Stereospecificity of amino acid side chains in deltorphin defines binding to opioid receptors. J Med Chem. 1992 Apr 3;35(7):1222–1227. doi: 10.1021/jm00085a009. [DOI] [PubMed] [Google Scholar]
  35. Lazarus L. H., Salvadori S., Santagada V., Tomatis R., Wilson W. E. Function of negative charge in the "address domain" of deltorphins. J Med Chem. 1991 Apr;34(4):1350–1355. doi: 10.1021/jm00108a017. [DOI] [PubMed] [Google Scholar]
  36. Lazarus L. H., Wilson W. E., Gaudino G., Irons B. J., Guglietta A. Evolutionary relationship between nonmammalian and mammalian peptides. Peptides. 1985;6 (Suppl 3):295–307. doi: 10.1016/0196-9781(85)90389-4. [DOI] [PubMed] [Google Scholar]
  37. Lazarus L. H., Wilson W. E., Guglietta A., de Castiglione R. Dermorphin interaction with rat brain opioid receptors: involvement of hydrophobic sites in the binding domain. Mol Pharmacol. 1990 Jun;37(6):886–892. [PubMed] [Google Scholar]
  38. Lazarus L. H., Wilson W. E., de Castiglione R., Guglietta A. Dermorphin gene sequence peptide with high affinity and selectivity for delta-opioid receptors. J Biol Chem. 1989 Feb 25;264(6):3047–3050. [PubMed] [Google Scholar]
  39. Li S., Zhu J., Chen C., Chen Y. W., Deriel J. K., Ashby B., Liu-Chen L. Y. Molecular cloning and expression of a rat kappa opioid receptor. Biochem J. 1993 Nov 1;295(Pt 3):629–633. doi: 10.1042/bj2950629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Meng F., Xie G. X., Thompson R. C., Mansour A., Goldstein A., Watson S. J., Akil H. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9954–9958. doi: 10.1073/pnas.90.21.9954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Mor A., Amiche M., Nicolas P. Enter a new post-translational modification: D-amino acids in gene-encoded peptides. Trends Biochem Sci. 1992 Dec;17(12):481–485. doi: 10.1016/0968-0004(92)90333-5. [DOI] [PubMed] [Google Scholar]
  42. Mor A., Delfour A., Sagan S., Amiche M., Pradelles P., Rossier J., Nicolas P. Isolation of dermenkephalin from amphibian skin, a high-affinity delta-selective opioid heptapeptide containing a D-amino acid residue. FEBS Lett. 1989 Sep 25;255(2):269–274. doi: 10.1016/0014-5793(89)81104-4. [DOI] [PubMed] [Google Scholar]
  43. Nikiforovich G. V., Hruby V. J., Prakash O., Gehrig C. A. Topographical requirements for delta-selective opioid peptides. Biopolymers. 1991 Jul;31(8):941–955. doi: 10.1002/bip.360310804. [DOI] [PubMed] [Google Scholar]
  44. O'Neill J. B., Pert C. B., Ruff M. R., Smith C. C., Higgins W. J., Zipser B. Identification and characterization of the opiate receptor in the ciliated protozoan, Tetrahymena. Brain Res. 1988 May 31;450(1-2):303–315. doi: 10.1016/0006-8993(88)91569-7. [DOI] [PubMed] [Google Scholar]
  45. Pattabiraman N., Sorensen K. R., Langridge R., Bhatnagar R. S., Renugopalakrishnan V., Rapaka R. S. Molecular mechanics studies of dermorphin. Biochem Biophys Res Commun. 1986 Oct 15;140(1):342–349. doi: 10.1016/0006-291x(86)91096-x. [DOI] [PubMed] [Google Scholar]
  46. Pert C. B., Pert A., Chang J. K., Fong B. T. (D-Ala2)-Met-enkephalinamide: a potent, long-lasting synthetic pentapeptide analgesic. Science. 1976 Oct 15;194(4262):330–332. doi: 10.1126/science.968485. [DOI] [PubMed] [Google Scholar]
  47. Quinn W. G., Gould J. L. Nerves and genes. Nature. 1979 Mar 1;278(5699):23–23. doi: 10.1038/278019a0. [DOI] [PubMed] [Google Scholar]
  48. Richter K., Egger R., Kreil G. D-alanine in the frog skin peptide dermorphin is derived from L-alanine in the precursor. Science. 1987 Oct 9;238(4824):200–202. doi: 10.1126/science.3659910. [DOI] [PubMed] [Google Scholar]
  49. Richter K., Egger R., Negri L., Corsi R., Severini C., Kreil G. cDNAs encoding [D-Ala2]deltorphin precursors from skin of Phyllomedusa bicolor also contain genetic information for three dermorphin-related opioid peptides. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4836–4839. doi: 10.1073/pnas.87.12.4836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Salvadori S., Bryant S. D., Bianchi C., Balboni G., Scaranari V., Attila M., Lazarus L. H. Phe3-substituted analogues of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by delta opioid receptors. J Med Chem. 1993 Nov 26;36(24):3748–3756. doi: 10.1021/jm00076a001. [DOI] [PubMed] [Google Scholar]
  51. Sasaki Y., Ambo A., Suzuki K. [D-Ala2]deltorphin II analogs with high affinity and selectivity for delta-opioid receptor. Biochem Biophys Res Commun. 1991 Oct 31;180(2):822–827. doi: 10.1016/s0006-291x(05)81138-6. [DOI] [PubMed] [Google Scholar]
  52. Schiller P. W., Nguyen T. M., Weltrowska G., Wilkes B. C., Marsden B. J., Lemieux C., Chung N. N. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists. Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11871–11875. doi: 10.1073/pnas.89.24.11871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Schiller P. W., Weltrowska G., Nguyen T. M., Wilkes B. C., Chung N. N., Lemieux C. Conformationally restricted deltorphin analogues. J Med Chem. 1992 Oct 16;35(21):3956–3961. doi: 10.1021/jm00099a025. [DOI] [PubMed] [Google Scholar]
  54. Schiller P. W., Weltrowska G., Nguyen T. M., Wilkes B. C., Chung N. N., Lemieux C. TIPP[psi]: a highly potent and stable pseudopeptide delta opioid receptor antagonist with extraordinary delta selectivity. J Med Chem. 1993 Oct 15;36(21):3182–3187. doi: 10.1021/jm00073a020. [DOI] [PubMed] [Google Scholar]
  55. Schwyzer R. ACTH: a short introductory review. Ann N Y Acad Sci. 1977 Oct 28;297:3–26. doi: 10.1111/j.1749-6632.1977.tb41843.x. [DOI] [PubMed] [Google Scholar]
  56. Sibinga N. E., Goldstein A. Opioid peptides and opioid receptors in cells of the immune system. Annu Rev Immunol. 1988;6:219–249. doi: 10.1146/annurev.iy.06.040188.001251. [DOI] [PubMed] [Google Scholar]
  57. Simon E. J. Opioid receptors and endogenous opioid peptides. Med Res Rev. 1991 Jul;11(4):357–374. doi: 10.1002/med.2610110402. [DOI] [PubMed] [Google Scholar]
  58. Smith D., Griffin J. F. Conformation of [Leu5]enkephalin from X-ray diffraction: features important for recognition at opiate receptor. Science. 1978 Mar 17;199(4334):1214–1216. doi: 10.1126/science.204006. [DOI] [PubMed] [Google Scholar]
  59. Tancredi T., Temussi P. A., Picone D., Amodeo P., Tomatis R., Salvadori S., Marastoni M., Santagada V., Balboni G. New insights on mu/delta selectivity of opioid peptides: conformational analysis of deltorphin analogues. Biopolymers. 1991 May;31(6):751–760. doi: 10.1002/bip.360310620. [DOI] [PubMed] [Google Scholar]
  60. Temussi P. A., Salvadori S., Amodeo P., Bianchi C., Guerrini R., Tomatis R., Lazarus L. H., Picone D., Tancredi T. Selective opioid dipeptides. Biochem Biophys Res Commun. 1994 Feb 15;198(3):933–939. doi: 10.1006/bbrc.1994.1133. [DOI] [PubMed] [Google Scholar]
  61. Teschemacher H., Koch G., Scheffler H., Hildebrand A., Brantl V. Opioid peptides. Immunological significance? Ann N Y Acad Sci. 1990;594:66–77. doi: 10.1111/j.1749-6632.1990.tb40468.x. [DOI] [PubMed] [Google Scholar]
  62. Toll L., Keys C., Polgar W., Loew G. The use of computer analysis in describing multiple opiate receptors. Neuropeptides. 1984 Dec;5(1-3):205–208. doi: 10.1016/0143-4179(84)90063-5. [DOI] [PubMed] [Google Scholar]
  63. Walker J. M., Berntson G. G., Sandman C. A., Coy D. H., Schally A. V., Kastin A. J. An analog of enkephalin having prolonged opiate-like effects in vivo. Science. 1977 Apr 1;196(4285):85–87. doi: 10.1126/science.190683. [DOI] [PubMed] [Google Scholar]
  64. Wang J. B., Imai Y., Eppler C. M., Gregor P., Spivak C. E., Uhl G. R. mu opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10230–10234. doi: 10.1073/pnas.90.21.10230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Wu C., Henry J. A. Interaction between ethanol and opioids in a protozoan assay. Hum Exp Toxicol. 1994 Mar;13(3):145–148. doi: 10.1177/096032719401300301. [DOI] [PubMed] [Google Scholar]
  66. Yasuda K., Raynor K., Kong H., Breder C. D., Takeda J., Reisine T., Bell G. I. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6736–6740. doi: 10.1073/pnas.90.14.6736. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES